Matías Chacón

1.2k total citations
56 papers, 429 citations indexed

About

Matías Chacón is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Matías Chacón has authored 56 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Matías Chacón's work include Sarcoma Diagnosis and Treatment (10 papers), Gastrointestinal Tumor Research and Treatment (8 papers) and Renal cell carcinoma treatment (7 papers). Matías Chacón is often cited by papers focused on Sarcoma Diagnosis and Treatment (10 papers), Gastrointestinal Tumor Research and Treatment (8 papers) and Renal cell carcinoma treatment (7 papers). Matías Chacón collaborates with scholars based in Argentina, United States and Brazil. Matías Chacón's co-authors include Diego Enrico, Reinaldo Chacón, Fernando Sánchez Loria, Martín Ángel, Enrique Roca, Ghada M. Salum, Mauro Orlando, Eduardo Huertas, Jacqueline M. O’Connor and José Mordoh and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Matías Chacón

49 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matías Chacón Argentina	13	192	191	100	79	71	56	429
Seong Woo Hong South Korea	11	234 1.2×	126 0.7×	85 0.8×	47 0.6×	43 0.6×	28	458
Marina Pulido France	10	315 1.6×	275 1.4×	48 0.5×	32 0.4×	134 1.9×	25	522
J-L. van Laethem Belgium	8	254 1.3×	132 0.7×	265 2.6×	70 0.9×	81 1.1×	14	520
Kouichiro Tsugawa Japan	10	196 1.0×	173 0.9×	214 2.1×	46 0.6×	15 0.2×	19	476
Ji Hyun Park South Korea	8	123 0.6×	146 0.8×	60 0.6×	35 0.4×	15 0.2×	22	307
Joanna Huszno Poland	11	193 1.0×	146 0.8×	61 0.6×	76 1.0×	25 0.4×	37	425
Sabrina Thieltges Germany	8	333 1.7×	181 0.9×	261 2.6×	24 0.3×	21 0.3×	8	467
Caio Rocha-Lima United States	10	315 1.6×	271 1.4×	289 2.9×	206 2.6×	82 1.2×	12	609
Takashi Ichimura Japan	12	361 1.9×	274 1.4×	143 1.4×	56 0.7×	76 1.1×	52	579
Yasuo Hosouchi Japan	15	221 1.2×	209 1.1×	197 2.0×	130 1.6×	50 0.7×	41	580

Countries citing papers authored by Matías Chacón

Since Specialization

Citations

This map shows the geographic impact of Matías Chacón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matías Chacón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matías Chacón more than expected).

Fields of papers citing papers by Matías Chacón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matías Chacón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matías Chacón. The network helps show where Matías Chacón may publish in the future.

Co-authorship network of co-authors of Matías Chacón

This figure shows the co-authorship network connecting the top 25 collaborators of Matías Chacón. A scholar is included among the top collaborators of Matías Chacón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matías Chacón. Matías Chacón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bruno, Luisina, Diego Enrico, Mora Amat, et al.. (2024). Impact of peridiagnostic genetic counseling and germline testing on treatment decisions for patients with triple negative breast cancer undergoing pembrolizumab-chemotherapy neoadjuvant approach.. Journal of Clinical Oncology. 42(16_suppl). e12633–e12633.

Chacón, Matías, et al.. (2024). Leveraging Patient Engagement Through Collaboration for Improved Global Health Outcomes in Sarcoma. American Society of Clinical Oncology Educational Book. 44(3). e438934–e438934. 1 indexed citations

Pestana, Roberto Carmagnani, Renée Zon Filippi, Veridiana Pires de Camargo, et al.. (2024). Sarcoma drug approvals in Latin America compared to the FDA and EMA: An analysis by the LACOG Sarcoma Group.. Journal of Clinical Oncology. 42(16_suppl). e13731–e13731. 1 indexed citations

Pestana, Roberto Carmagnani, Veridiana Pires de Camargo, Rodrigo Ramella Munhoz, et al.. (2024). Challenges and opportunities for sarcoma care and research in Latin America: a position paper from the LACOG sarcoma group. The Lancet Regional Health - Americas. 30. 100671–100671. 1 indexed citations

Nadal, Jorge, et al.. (2024). The Emerging Role of Tertiary Lymphoid Structures in Breast Cancer: A Narrative Review. Cancers. 16(2). 396–396. 9 indexed citations

Bourlon, María T., Laurence Albigès, Matías Chacón, et al.. (2024). Subcutaneous (SC) nivolumab (NIVO) vs intravenous (IV) NIVO in patients with previously treated advanced or metastatic clear cell renal cell carcinoma (ccRCC): Safety and patient-reported outcomes (PROs) of the randomized phase 3 CheckMate 67T trial.. Journal of Clinical Oncology. 42(16_suppl). 4532–4532. 2 indexed citations

Aguirre, Elena, Diego Enrico, Diego Kaen, et al.. (2023). P2.18-04 Real-world Study on Efficacy of First-Line Nivolumab + Ipilimumab in Unresectable Malignant Pleural Mesothelioma (ImmunoMeso). Journal of Thoracic Oncology. 18(11). S382–S382. 1 indexed citations

Loria, Fernando Sánchez, et al.. (2023). Short-course radiotherapy for rectal cancer: real-world evidence in Argentina. ecancermedicalscience. 17. 1555–1555. 1 indexed citations

Enrico, Diego, Andrés Rodríguez, Luisina Bruno, et al.. (2023). Atypical pattern of response in rectal cancer after neoadjuvant pembrolizumab treatment: a case report, literature review, and proposed management model. Journal of Gastrointestinal Oncology. 14(3). 1635–1642. 2 indexed citations

10.

Ángel, Martín, et al.. (2022). Experience of bipolar androgen therapy (BAT) in Argentinian oncology centres. ecancermedicalscience. 16. 1480–1480. 1 indexed citations

11.

Enrico, Diego, et al.. (2022). Overcoming Resistance to Osimertinib by T790M Loss and C797S Acquisition Using Gefitinib in a Patient With EGFR-Mutant NSCLC: A Case Report. JTO Clinical and Research Reports. 4(2). 100456–100456. 9 indexed citations

12.

López, Carlos, et al.. (2022). Assessing the methodological quality of quality-of-life analyses in first-line non-small cell lung cancer trials: A systematic review. Critical Reviews in Oncology/Hematology. 176. 103747–103747. 6 indexed citations

13.

Enrico, Diego, et al.. (2021). Analysis of adverse events attribution and reporting in cancer clinical trials: A systematic review. Critical Reviews in Oncology/Hematology. 160. 103296–103296. 6 indexed citations

14.

Vas, Jaya, Carlos H. Barrios, Daniel Herchenhorn, et al.. (2016). Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma. OncoTargets and Therapy. Volume 9. 5839–5845. 8 indexed citations

15.

Loria, Fernando Sánchez, Soledad Iseas, Juan Manuel O’Connor, et al.. (2016). Non-surgical management of rectal cancer. Series of 68 cases, long follow up in two leading centres in Argentina. Digestive and Liver Disease. 48(11). 1372–1377. 14 indexed citations

16.

Barrios, Carlos H., Martin E. Blackstein, Jean‐Yves Blay, et al.. (2015). The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours. European Journal of Cancer. 51(16). 2423–2433. 25 indexed citations

17.

Euw, Erika M. von, María Marcela Barrio, David Furman, et al.. (2008). A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression. Journal of Translational Medicine. 6(1). 6–6. 58 indexed citations

18.

Blajman, C., Luis Fein, Matías Chacón, et al.. (2008). Pharmacokinetic equivalence observed between an emulsion formulation of vinorelbine (ANX-530) and vinorelbine solution in a clinical study of patients with advanced cancer.. Cancer Research. 68. 207–207. 1 indexed citations

19.

Chacón, Matías, Ernesto Korbenfeld, Santiago Bella, et al.. (2006). Irinotecan, Oxaliplatin Plus Bolus 5-Fluorouracil and Low Dose Folinic Acid Every 2 Weeks. American Journal of Clinical Oncology. 29(1). 45–51. 6 indexed citations

20.

Orlando, Mauro, et al.. (2000). Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer. Annals of Oncology. 11(2). 177–181. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact